Poster Presentation
Enhancing Dose Selection in Phase I Cancer Trials: Extending the Bayesian Logistic Regression Model with Non-DLT Adverse Events Integration
The poster showcases an innovative statistical method our Clinical Biometry team developed in-house. This method aims to optimize the dose-escalation process in early-phase oncology clinical trials.
Presented by Luca Genetti, Associate Biostatistician
